Abstract

Programmed death-ligand 1 testing in patients with non-small cell lung cancer: Ready for prime time?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
MTE09.02 Biomarkers for Targeted Therapies and Immune Checkpoint Inhibitors in Advanced NSCLC
Sabine Zöchbauer-Müller
Journal of Thoracic Oncology | VOL. 12
Sabine Zöchbauer-MüllerSabine Zöchbauer-Müller
01 Jan 2017
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.
Andrew C Wotherspoon ... Birgit Guldhammer Skov
Journal of clinical oncology : official journal of the American Society of Clinical Oncology | VOL. 35
Andrew C Wotherspoon, et. al.Andrew C Wotherspoon ... Birgit Guldhammer Skov
20 Oct 2017
Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.
Peter E Fecci ... David Reardon
Neuro-oncology | VOL. 17
Peter E Fecci, et. al.Peter E Fecci ... David Reardon
10 May 2015
Moving Programmed Death-1 Inhibitors to the Front Lines in Non-Small-Cell Lung Cancer.
Justin F Gainor
Journal of clinical oncology : official journal of the American Society of Clinical Oncology | VOL. 34
Justin F GainorJustin F Gainor
05 Jul 2016
View more papers

More From: Cancer cytopathology

Paper Title
Journal
Date
Author
Research and scholarly mentoring: A guide for pathology faculty and program directors.
R Lane Coffee ... Stephen John Cico
Cancer cytopathology | VOL. -
R Lane Coffee, et. al.R Lane Coffee ... Stephen John Cico
23 May 2024
Malignant risk of pediatric Bethesda category III thyroid nodules subcategorized by nuclear atypia and other: A single institution experience.
Xiaobing Jin ... Amer Heider
Cancer cytopathology | VOL. -
Xiaobing Jin, et. al.Xiaobing Jin ... Amer Heider
21 May 2024
Current role of cytopathology in the molecular and computational era: The perspective of young pathologists.
Alessandro Caputo ... Vincenzo L'Imperio
Cancer cytopathology | VOL. -
Alessandro Caputo, et. al.Alessandro Caputo ... Vincenzo L'Imperio
15 May 2024
A systematic review on performance characteristics of FNA of renal lesions: It is time for a standardized classification system.
Kübra Katipoglu ... Güliz A Barkan
Cancer cytopathology | VOL. -
Kübra Katipoglu, et. al.Kübra Katipoglu ... Güliz A Barkan
07 May 2024
View more papers